Diabetes, obesity & metabolism
GLP-1RAs versus metformin and Parkinson's risk in type 2 diabetes.
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, Yitian Yang, Shuang Lv, Mengrong Miao, Wan-Ming Chen, Szu-Yuan Wu, Jiaqiang Zhang
Published: 202610.1111/dom.70459
Abstract
BACKGROUND: Parkinson's disease (PD) is an increasingly prevalent neurodegenerative condition, particularly among individuals with type 2 diabetes mellitus (T2DM). While prior studies have suggested that GLP-1 receptor agonists (GLP-1RAs) and metform…
Preview only. Read the full abstract at the source